A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).
Teicher
B A
BA
Dana-Farber Cancer Institute, Boston, MA 02115, USA.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*